STOCKHOLM, Sept. 30, 2020 /PRNewswire/ -- C-RAD
announced today that multiple sites in the state of New South Wales, Australia decided to
implement C-RAD's Catalyst+ HD™ and Sentinel 4DCT™
In total four sites in the state of New South Wales of are going to be equipped
with the C-RAD solution over the next months.
The Catalyst+ HD™ system is delivered with the complete software
suite with modules for Respiratory Gating, Patient Setup and
Positioning and Motion Monitoring. The C-RAD SIGRT solution
provides a continuous monitoring of the patient during a treatment
fraction. Patient motion above a clinically defined threshold will
interrupt the treatment beam.
C-RAD Sentinel 4DCT is an easy-to-use, laser-based optical
surface scanning system with functionality for four-dimensional CT
image reconstruction and gated imaging in a CT room.
Jason Beirne, Managing Director
of Gamma Gurus, comments:
"Surface guided motion management in radiation therapy is
rapidly becoming standard of care and we are very excited to be
part of this large-scale roll-out in the New South Wales health system. Soon more
patients across the state will benefit from highly accurate motion
and respiratory tracking that will enhance their overall level of
care. We are also very proud to be partnered with C-RAD whose
innovative products lead the way in Surface Guidance."
C-RAD is partnering with the company Gamma Gurus in Australia. Gamma Gurus is a distribution
"I am proud to see that the customers have chosen C-RAD and
Gamma Gurus as a partner for the surface tracking solution. We are
looking forward to support the clinical implementation and to
provide the benefits that the technology offers to users and
patients in New South Wales." says
Tim Thurn, CEO and President of
C-RAD AB. "The adaption of motion management is rapidly increasing
in Australia but also globally.
Depending on the clinical profile of a given radiation therapy
center, 70% of the patients that receive radiation therapy benefit
from our solutions. This technology is clearly on its way to become
standard of care in advanced radiation therapy."
The total order received from Gamma Gurus has a value of just
above 11 MSEK for C-RAD. Delivery and installation are expected to
commence before the end of the year.
C-RAD develops surface-guided imaging solutions for radiation
therapy to allow highly accurate dose delivery to the tumor, and at
the same time, to protect healthy tissue from unwanted exposure.
Using high-speed 3D cameras combined with augmented reality, C-RAD
supports the initial patient setup process and monitors the
patient's motion during treatment to ensure high confidence, an
efficient workflow, and improved accuracy. C-RAD monitors the
patient's motion without the use of tattoos or additional imaging
dose, to deliver the highest level of patient safety and
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ OMX Stockholm.
For more information on C-RAD, please visit
For further information:
Tim Thurn, CEO C-RAD AB, Phone
+46-18-666930, Email email@example.com
This information is information that C-RAD AB (publ) is obliged
to make public pursuant to the EU Market Abuse Regulation. The
information was submitted for publication, through the agency of
the contact person set out above, at 11:15
CET on September 30, 2020.
This information was brought to you by Cision
The following files are available for download: